大悅城地產(00207.HK)16.4億人幣投得海南三亞地塊 擬發展多用途綜合體及服務型公寓
大悅城地產(00207.HK)公布,間接附屬公司三亞嘉悅已接獲確認書,批准其以16.39億元人民幣(下同)競得位於中國海南省三亞市的地塊,總地盤面積約6.33萬平方米,擬定用於商用及服務式公寓。
公司預期將於2019年12月24日或之前簽訂有關收購事項的土地使用權出讓合同。三亞嘉悅已支付一筆共9.83億元的款項作為拍賣會的保證金。緊隨收購事項完成後,公司將間接於該地塊中擁有權益。
公司指,鑒於該地塊的位置及指定用途,預計將用於大悅城城市多用途綜合體及服務型公寓的開發,旨在於該地塊開發完成後實現高投資價值,從而為集團帶來穩定的收入及利潤。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.